UMIN ID: C000000343
Registered date:01/03/2006
Clinical dose-escalation study of auto-gammadelta T cell therapy for multiple myeloma to investigate its safety and efficacy
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Multiple myeloma |
| Date of first enrollment | 2005/11/01 |
| Target sample size | 4 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Gammadelta T cell is to be administrated intravenously four times on a biweekly-basis. |
Outcome(s)
| Primary Outcome | Safety : Adverse events |
|---|---|
| Secondary Outcome | Efficacy : Improvement and maintenance of tumor-related immuno/biochemistrical parameters |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Patients who have : uncontrolled infections; active autoimmune diseases; serious cardiac disease; other cancers, and who have received continuous systemic steroids |
Related Information
| Primary Sponsor | Japanese Red Cross Medical Center |
|---|---|
| Secondary Sponsor | Shin-Yokohama Medical Clinic |
| Source(s) of Monetary Support | Medinet Co., Ltd. |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | 03-3400-1311 |
| Affiliation | Japanese Red Cross Medical Center Hematological department |
| scientific contact | |
| Name | Kenshi Suzuki |
| Address | 4-1-22 Hiroo, Shibuya-ku, Tokyo 150-8935, Japan Japan |
| Telephone | |
| Affiliation | Japanese Red Cross Medical Center Hematological department |